On February 24, 2016, At its meeting today, the Supervisory Board of Bayer AG announced that they have approved the Board of Management’s recommendation that a dividend payment of EUR 2.50 (2014: EUR 2.25) per share be proposed to the Annual Stockholders’ Meeting on April 29, 2016 (Press release, Bayer, FEB 24, 2016, View Source [SID:1234509168]). "2015 was a very good year for Bayer. We would like our stockholders to share appropriately in this success," explained Bayer CEO Dr. Marijn Dekkers. With 826,947,808 shares entitled to the dividend, the total dividend payment would amount to EUR 2,067 million (2014: EUR 1,861 million), an increase of 11.1 percent.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Bayer Group’s consolidated financial statements for 2015 will be presented and discussed at the Financial News Conference on February 25, 2016.